140 related articles for article (PubMed ID: 10102786)
1. Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys.
Jentsch JD; Taylor JR; Redmond DE; Elsworth JD; Youngren KD; Roth RH
Psychopharmacology (Berl); 1999 Feb; 142(1):78-84. PubMed ID: 10102786
[TBL] [Abstract][Full Text] [Related]
2. Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: involvement in frontostriatal cognitive deficits.
Jentsch JD; Taylor JR; Elsworth JD; Redmond DE; Roth RH
Neuroscience; 1999 Mar; 90(3):823-32. PubMed ID: 10218783
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat.
Umino A; Takahashi K; Nishikawa T
Br J Pharmacol; 1998 May; 124(2):377-85. PubMed ID: 9641556
[TBL] [Abstract][Full Text] [Related]
4. Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration.
Elsworth JD; Groman SM; Jentsch JD; Valles R; Shahid M; Wong E; Marston H; Roth RH
Neuropharmacology; 2012 Mar; 62(3):1442-52. PubMed ID: 21875607
[TBL] [Abstract][Full Text] [Related]
5. Object retrieval/detour deficits in monkeys produced by prior subchronic phencyclidine administration: evidence for cognitive impulsivity.
Jentsch JD; Roth RH; Taylor JR
Biol Psychiatry; 2000 Sep; 48(5):415-24. PubMed ID: 10978725
[TBL] [Abstract][Full Text] [Related]
6. Effects of NRA0045, a novel potent antagonist at dopamine D4, 5-HT2A, and alpha1 adrenaline receptors, and NRA0160, a selective D4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats.
Abekawa T; Honda M; Ito K; Koyama T
Psychopharmacology (Berl); 2003 Sep; 169(3-4):247-56. PubMed ID: 12898123
[TBL] [Abstract][Full Text] [Related]
7. The selective dopamine D4 receptor antagonist, PNU-101387G, prevents stress-induced cognitive deficits in monkeys.
Arnsten AF; Murphy B; Merchant K
Neuropsychopharmacology; 2000 Oct; 23(4):405-10. PubMed ID: 10989267
[TBL] [Abstract][Full Text] [Related]
8. Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine D₂ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats.
Oyamada Y; Horiguchi M; Rajagopal L; Miyauchi M; Meltzer HY
Behav Brain Res; 2015 May; 285():165-75. PubMed ID: 25448429
[TBL] [Abstract][Full Text] [Related]
9. Clozapine normalizes prefrontal cortex dopamine transmission in monkeys subchronically exposed to phencyclidine.
Elsworth JD; Jentsch JD; Morrow BA; Redmond DE; Roth RH
Neuropsychopharmacology; 2008 Feb; 33(3):491-6. PubMed ID: 17507917
[TBL] [Abstract][Full Text] [Related]
10. Clozapine, SCH 23390 and alpha-flupenthixol but not haloperidol attenuate acute phencyclidine-induced disruption of conditional discrimination performance.
Dunn MJ; Killcross S
Psychopharmacology (Berl); 2007 Mar; 190(4):403-14. PubMed ID: 17237918
[TBL] [Abstract][Full Text] [Related]
11. Clozapine but not haloperidol treatment reverses sub-chronic phencyclidine-induced disruption of conditional discrimination performance.
Dunn MJ; Killcross S
Behav Brain Res; 2006 Dec; 175(2):271-7. PubMed ID: 17027093
[TBL] [Abstract][Full Text] [Related]
12. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine.
Jentsch JD; Redmond DE; Elsworth JD; Taylor JR; Youngren KD; Roth RH
Science; 1997 Aug; 277(5328):953-5. PubMed ID: 9252326
[TBL] [Abstract][Full Text] [Related]
13. F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms.
Depoortère R; Auclair AL; Bardin L; Bruins Slot L; Kleven MS; Colpaert F; Vacher B; Newman-Tancredi A
Br J Pharmacol; 2007 May; 151(2):266-77. PubMed ID: 17375085
[TBL] [Abstract][Full Text] [Related]
14. Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion.
Jentsch JD; Taylor JR; Roth RH
Neuropsychopharmacology; 1998 Aug; 19(2):105-13. PubMed ID: 9629564
[TBL] [Abstract][Full Text] [Related]
15. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.
Broderick PA; Piercey MF
J Neural Transm (Vienna); 1998; 105(6-7):749-67. PubMed ID: 9826116
[TBL] [Abstract][Full Text] [Related]
16. Primate phencyclidine model of schizophrenia: sex-specific effects on cognition, brain derived neurotrophic factor, spine synapses, and dopamine turnover in prefrontal cortex.
Elsworth JD; Groman SM; Jentsch JD; Leranth C; Redmond DE; Kim JD; Diano S; Roth RH
Int J Neuropsychopharmacol; 2014 Oct; 18(6):. PubMed ID: 25522392
[TBL] [Abstract][Full Text] [Related]
17. The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat.
Abdul-Monim Z; Reynolds GP; Neill JC
J Psychopharmacol; 2003 Mar; 17(1):57-65. PubMed ID: 12680740
[TBL] [Abstract][Full Text] [Related]
18. Clozapine ameliorates epigenetic and behavioral abnormalities induced by phencyclidine through activation of dopamine D1 receptor.
Aoyama Y; Mouri A; Toriumi K; Koseki T; Narusawa S; Ikawa N; Mamiya T; Nagai T; Yamada K; Nabeshima T
Int J Neuropsychopharmacol; 2014 May; 17(5):723-37. PubMed ID: 24345457
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of haloperidol on phencyclidine-induced reduction in substance P contents in rat brain regions.
Shirayama Y; Mitsushio H; Takahashi K; Nishikawa T
Synapse; 2000 Mar; 35(4):292-9. PubMed ID: 10657039
[TBL] [Abstract][Full Text] [Related]
20. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat.
Jentsch JD; Tran A; Le D; Youngren KD; Roth RH
Neuropsychopharmacology; 1997 Aug; 17(2):92-9. PubMed ID: 9252984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
